miRNAs in pancreatic cancer progression and metastasis
Small non-coding RNA or microRNA (miRNA) are critical regulators of eukaryotic cells.
Dysregulation of miRNA expression and function has been linked to a variety of diseases …
Dysregulation of miRNA expression and function has been linked to a variety of diseases …
The role of metabolic reprogramming in pancreatic cancer chemoresistance
C Liu, C Li, Y Liu - Frontiers in Pharmacology, 2023 - frontiersin.org
Pancreatic cancer is characterized by hidden onset, high malignancy, and early metastasis.
Although a few cases meet the surgical indications, chemotherapy remains the primary …
Although a few cases meet the surgical indications, chemotherapy remains the primary …
The role of amino acid metabolism alterations in pancreatic cancer: From mechanism to application
S Fu, S Xu, S Zhang - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2023 - Elsevier
The incidence of pancreatic cancer is increasing in both developed and developing Nations.
In recent years, various research evidence suggested that reprogrammed metabolism may …
In recent years, various research evidence suggested that reprogrammed metabolism may …
The Link between Diabetes, Pancreatic Tumors, and miRNAs—New Players for Diagnosis and Therapy?
M Kozłowska, A Śliwińska - International Journal of Molecular Sciences, 2023 - mdpi.com
Despite significant progress in medicine, pancreatic cancer is one of the most tardily
diagnosed cancer and is consequently associated with a poor prognosis and a low survival …
diagnosed cancer and is consequently associated with a poor prognosis and a low survival …
Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma
C Caputo, M Falco, A Grimaldi, A Lombardi, CC Miceli… - Cancers, 2024 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive
and deadliest cancers worldwide, with an overall survival rate of< 10% at 5 years. For most …
and deadliest cancers worldwide, with an overall survival rate of< 10% at 5 years. For most …
Targeting aberrant amino acid metabolism for pancreatic cancer therapy: Opportunities for nanoparticles
X Zang, K Lei, J Wang, R Gong, C Gao, Z Jing… - Chemical Engineering …, 2024 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal malignancies with
insidious initiation and early metastasis. The autonomous reprogramming of amino acid …
insidious initiation and early metastasis. The autonomous reprogramming of amino acid …
非小细胞肺癌A549 细胞基因组不稳定性和MYC 基因突变在吉西他滨耐药中的作用.
陈宗军， 陈亚红， 黄丽云… - Journal of Jilin University …, 2024 - search.ebscohost.com
目的: 探讨非小细胞肺癌(NSCLC) A549 细胞基因不稳定性和MYC 基因突变在吉西他滨耐药中
的作用, 并阐明其作用机制. 方法: 采用2 mg· L-1 吉西他滨持续作用A549 细胞(A549 组) …
的作用, 并阐明其作用机制. 方法: 采用2 mg· L-1 吉西他滨持续作用A549 细胞(A549 组) …